High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
AssigneeNeXstar Pharmaceuticals, Inc.
InventorsBarry Polisky, Robert D. Jenison, Larry Gold
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeXstar Pharmaceuticals, Inc.
InventorsBarry Polisky, Robert D. Jenison, Larry Gold
Estimating the term…
Methods are described for the identification and preparation of nucleic acid ligand ligands to theophylline and caffeine. Included in the invention is a method for identifying nucleic acid ligands with high affinity and selectivity for a target molecule, termed counter-SELEX. One embodiment of counter-SELEX is comprised of the steps of a) preparing a candidate mixture of nucleic acids; b) contacting the candidate mixture with the target, wherein nucleic acids having an increased affinity to the target relative to the candidate mixture may be partitioned form the remainder of the candidate mixture; partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; d) contacting the increased affinity nucleic acids with one or more non-target molecules such that nucleic acid ligands to the non-target molecule(s) are removed; and e) amplifying the nucleic acids with specific affinity to the target molecule to yield a mixture of nucleic acids enriched for nucleic acid sequences with a relatively higher affinity and specificity for binding to the target molecule. Included in the invention are specific nucleic acid ligands to theophylline identified by the method of counter-SELEX.
A method for identifying nucleic acid ligands to a target molecule comprising:
A purified and isolated non-naturally occurring RNA ligand to theophylline, wherein the nucleotide sequence of said RNA ligand is selected from the group consisting of the nucleotide sequences set forth in FIGS. 2A and 2B (SEQ ID NOS:
Nucleic acid ligands to theophylline identified according to a method for identifying nucleic acid ligands from a candidate mixture comprised of nucleic acids, said method comprising:
Nucleic acid ligands to caffeine identified according to a method for identifying nucleic acid ligands from a candidate mixture comprised of nucleic acids, said method comprising:
A non-naturally occurring nucleic acid ligand, having a specific binding affinity for a target molecule, wherein said nucleic acid ligand is not a nucleic acid having the known physiological function of being bound by the target molecule, and wherein said target molecule is selected from the group consisting of theophylline and caffeine.
A method for identifying nucleic acid ligands to a target molecule comprising:
Dependencies are inferred from the claim text.